Home » Archive by Category


San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.

Biocom Announces 2014 Elected Official of the Year

October 23, 2014 – 11:15 am | Edit Post

SAN DIEGO, Oct. 23, 2014 /PRNewswire/ — Biocom, the association for the Southern California life science community, today announced that Congressman Scott Peters (D-52) will be honored as Biocom’s 2014 Elected Official of the Year at the Biocom Celebration of Life Annual Dinner on November 20, 2014.

“It is my great pleasure to announce that Congressman Scott Peters will be our 2014 Elected Official of the Year,” said Joe Panetta, President and CEO of Biocom. “During his two years in office, Congressman Peters has not only recognized the importance of the life science industry to his district, but has consistently used that platform to emphasize the importance of the industry to our nation.”

“Congressman Peters made increased funding for the National Institutes of Health (NIH) a top priority in 2014. The NIH is a major source of funding for biomedical research for academic and non-profit institutions, and many of the world’s top research facilities are in or adjacent to Congressman Peters’ district.  This year he has introduced legislation allowing increased research tax credits to incentivize and accelerate biomedical research, to provide tax credits for biofuel production, and to establish a Commission to quantify the overall health care savings that can be achieved through utilization of wireless health technologies.” 

The life science community is one of the economic cornerstones of the region, with a majority of the cluster located in the City of San Diego. It is one of the few local industries which continued to grow during the recession, and provides over 110,000 jobs, paying an average of $100,000 per employee per year.

“Our life science companies and research institutions make life-changing and life-saving discoveries every day and they are creating the high-skill jobs of the future for our children,” said Rep. Scott Peters. “It’s been my honor to represent this critical industry in the U.S. Congress and I am grateful to Biocom and its board members for teaching me so much about what I can do to support this innovative work. I will continue to fight for investment in scientific research and for good legislation that helps pave the way for America’s competitiveness in the life sciences.”

Biocom’s Annual Dinner is one of the association’s premier flagship events; the dinner brings together the finest of the state’s Life Science executives and leaders in a celebration of the year’s achievements in the Life Sciences industry. With expected sold-out attendance of over 800, the city and state’s life science and political elite will be in attendance at this prestigious event.

About Biocom

Biocom is one of the largest regional life science associations in the world, representing more than 600 member companies in Southern California. The association focuses on initiatives that position the region’s life science industry competitively on the world stage, and on the development and delivery of innovative products that improve health and quality of life. For more information on Biocom or the Southern California biotechnology and medical device community, please visit the organization’s Web site at http://www.biocom.org or call (858) 455-0300.

Logo - http://photos.prnewswire.com/prnh/20130228/LA69104LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/biocom-announces-2014-elected-official-of-the-year-718824988.html

Why people with Down syndrome invariably develop Alzheimer’s disease

October 23, 2014 – 9:32 am | Edit Post

How beta-amyloid plaques are made in individuals with Down syndrome and Alzheimer’s pateints.

Industry-Leading Speakers Present Next Month at Managed Care Account Management Training in San Francisco

October 23, 2014 – 8:30 am | Edit Post

BURLINGTON, Mass., Oct. 23, 2014 /PRNewswire/ — Decision Resources Group is pleased to host seven expert speakers who will deliver comprehensive training presentations during its managed care Account Management Training (AMT) taking place in San Francisco in November. AMT is a three-day conference providing comprehensive hands-on training that will give account managers knowledge, techniques, and confidence to successfully work with their managed care accounts. AMT is considered a “gold-standard” within the pharmaceutical and biotech industry training over 1,000 account managers.

Below are the industry experts who will present at AMT:

Charles Bell is Director of New Business Development at Express Scripts, where his responsibilities include working with clients to develop and enhance specialty pharmacy and specialty distribution channels for new and existing specialty products. He is responsible for pharmaceutical and biotech client strategies which include successfully contracting and maximizing distribution channel solutions.
Kirby J. Eng, RPh is Executive Director of Clinical Oncology Management Services at Onco 360, where he oversees the development and implementation of oncology pharmacy management services. Onco360 is the largest independent oncology pharmacy services organization in the U.S.
Patrick W. Finnerty is the owner of PWF Consulting, which provides consulting services to several healthcare organizations. His previous experience includes a 32 year career in Virginia state government, during which he was appointed by two Governors to serve as Virginia’s Medicaid Director from 2002 to 2010.
William Fleming, PharmD is Segment Vice President at Humana Inc. and President, Humana Pharmacy Solutions. A 20 year Humana veteran, Dr. Fleming oversees pharmacy operations and business strategy that services all Humana segments, including its non-Humana membership. He also serves as a key leader for Humana’s Healthcare Services segment.
James T. Kenney, Jr., RPh, MBA is Pharmacy Operations Manager at Harvard Pilgrim Health Care, Inc. A 34 year veteran of the company, Mr. Kenney has held several positions including Staff Pharmacist, Chief Pharmacist, Assistant Administrator for Pharmacy Programs and Pharmacy Operations Manager. Currently, he is responsible for the pharmacy contracting program with pharmaceutical manufacturers and specialty pharmacy providers.
Neil Minkoff, MD is the Founder and CEO FountainHead HealthCare. In 2010, he founded the company as a reaction to the ever-growing complexity of the healthcare system and the need for independent thinkers who could provide some clarity in the chaos. Dr. Minkoff is also the lead physician for EmpiraMed, Inc., working to develop Patient Reported Outcome tools.
Rebecca Waller is a Principal Training Consultant at Decision Resources Group, where she provides guidance on managed care, formulary data, trends and other current health insurance market topics to account managers and sales managers.Session topics at AMT include “U.S. Managed Markets Overview,” “Pricing and Contracting,” “Effectively Working in Today’s State Medicaid Arena,” “Critical Essentials Necessary for Success in Specialty Pharmacy” and “An In-depth Look at our Current Medicare System.”

AMT will take place at The Hyatt Regency in San Francisco on November 18-20, 2014. The cost is $3,795 per person with discounts available to groups of five or more. For more information and to register, click here.

Media interested in attending the conference should contact Briana Pontremoli at bpontremoli@dresourcesgroup.com or 781-993-2654 for additional information.

About Decision Resources Group

Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. Clients rely on this analysis and data to make informed decisions. Find out more at www.DecisionResourcesGroup.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

Decision Resources GroupBriana Pontremoli781-993-2654 bpontremoli@dresourcesgroup.com

Logo - http://photos.prnewswire.com/prnh/20130103/MM36768LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/industry-leading-speakers-present-next-month-at-managed-care-account-management-training-in-san-francisco-336276908.html
SOURCE Decision Resources Group

Aurora Spine Announces Expansion of U.S. Hospital Network Through Agreement With MedAssets

October 23, 2014 – 6:01 am | Edit Post

CARLSBAD, CALIFORNIA–(Marketwired – Oct. 23, 2014) – Aurora Spine Corporation (TSX VENTURE:ASG) announced it has entered into a national contract with MedAssets. MedAssets is one of the nation’s largest third-party providers of supply chain management and outsourced procurement capabilities. MedAssets manages, on behalf of its clients, more than $50 billion in supply expense per year through the MedAssets National Procurement Center.

Flint Rehabilitation Devices Introduces MusicGlove, World???s First FDA Approved, Clinically Validated Music-Based Hand Rehabilitation Device

October 23, 2014 – 5:00 am | Edit Post

IRVINE, Calif.–(BUSINESS WIRE)–Flint Rehabilitation Devices today introduced MusicGlove (#musicglove), the worlds first FDA approved, clinically validated hand rehabilitation (#rehabilitation) device that uses music and gaming to make therapy (#therapy) fun and effective for the over six million people with stroke or other neurological or muscular injuries. The device, which helps increase users…

TearLab Corporation To Release Q3 2014 Financial Results On November 5, 2014

October 23, 2014 – 5:00 am | Edit Post

SAN DIEGO, Oct. 22, 2014 (GLOBE NEWSWIRE) — TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) (“TearLab” or the “Company”) expects to announce its Q3 2014 financial results after market closes on Wednesday November 5, 2014. TearLab is pleased to invite all willing participants in a conference call during…

Flint Rehabilitation Devices Introduces MusicGlove, World???s First FDA Approved, Clinically Validated Music-Based Hand Rehabilitation Device

October 23, 2014 – 5:00 am | Edit Post

IRVINE, Calif.–(BUSINESS WIRE)–Flint Rehabilitation Devices today introduced MusicGlove (#musicglove), the worlds first FDA approved, clinically validated hand rehabilitation (#rehabilitation) device that uses music and gaming to make therapy (#therapy) fun and effective for the over six million people with stroke or other neurological or muscular injuries. The device, which helps increase users…

Rich Pharmaceuticals Announces Submission Of Investigational New Drug (IND) Application To FDA For The Treatment Of Acute Myelocytic Leukemia And Myelodysplastic Syndrome

October 23, 2014 – 5:00 am | Edit Post

BEVERLY HILLS, Calif., Oct. 23, 2014 (GLOBE NEWSWIRE) — Rich Pharmaceuticals, Inc. (OTCQB:RCHA) (“Rich” or the “Company”), a clinical-stage biotechnology company focused on developing innovative therapies in oncology, announced today that it has submitted an investigational new drug (IND) application…

Reflow Wins FDA Approval And Initial US Clinical Use Of The Wingman35 Crossing Catheter

October 23, 2014 – 5:00 am | Edit Post

Reflow Medical Corporation Announces FDA 510(K) Clearance And Initial US Clinical Use Of The Wingman35 Crossing CatheterSAN CLEMENTE, Calif.–(BUSINESS WIRE)–ReFlow Medical, Inc. (ReFlow) today announced FDA clearance for US commercialization of their Wingman35 Crossing Catheter for use in the peripheral vasculature as well as the first US clinical cases with…

MediciNova, Inc. Announces FDA Granted Orphan Drug Designation To MN-001 (Tipelukast) For Idiopathic Pulmonary Fibrosis (IPF)

October 23, 2014 – 5:00 am | Edit Post

LA JOLLA, Calif., Oct. 22, 2014 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (Nasdaq:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:4875), today announced that the U.S. Food and Drug Administration (FDA) has granted orphan…